These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 4086476)
1. Human histidine-rich glycoprotein: simultaneous purification with antithrombin III and characterization of its gross structure. Koide T; Odani S; Ono T J Biochem; 1985 Nov; 98(5):1191-200. PubMed ID: 4086476 [TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of the seven cyanogen bromide fragments of human serum transferrin. Sutton MR; Brew K Biochem J; 1974 Apr; 139(1):163-8. PubMed ID: 4463940 [TBL] [Abstract][Full Text] [Related]
3. Metal ion affinity adsorption of a Zn(II)-transport protein present in maternal plasma during lactation: structural characterization and identification as histidine-rich glycoprotein. Yip TT; Hutchens TW Protein Expr Purif; 1991; 2(5-6):355-62. PubMed ID: 1821809 [TBL] [Abstract][Full Text] [Related]
4. New method for purifying histidine-rich glycoprotein from human plasma redefines its functional properties. Patel KK; Poon IK; Talbo GH; Perugini MA; Taylor NL; Ralph TJ; Hoogenraad NJ; Hulett MD IUBMB Life; 2013 Jun; 65(6):550-63. PubMed ID: 23576524 [TBL] [Abstract][Full Text] [Related]
5. [Isolation, composition, and physicochemical properties of 9 peptides released by the action of cyanogen bromide on human serotransferrin]. Charet P C R Acad Hebd Seances Acad Sci D; 1975 May; 280(17):2049-52. PubMed ID: 807391 [TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'. Koide T; Takahashi K; Odani S; Ono T; Sakuragawa N Thromb Res; 1983 Jul; 31(2):319-28. PubMed ID: 6636046 [TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of antithrombin III from human, porcine and rabbit plasma, and rat serum. Koide T J Biochem; 1979 Dec; 86(6):1841-50. PubMed ID: 118968 [TBL] [Abstract][Full Text] [Related]
8. Zinc as a cofactor for heparin neutralization by histidine-rich glycoprotein. Kluszynski BA; Kim C; Faulk WP J Biol Chem; 1997 May; 272(21):13541-7. PubMed ID: 9153200 [TBL] [Abstract][Full Text] [Related]
9. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes. Gorgani NN; Parish CR; Easterbrook Smith SB; Altin JG Biochemistry; 1997 Jun; 36(22):6653-62. PubMed ID: 9184145 [TBL] [Abstract][Full Text] [Related]
10. The heparin-binding site(s) of histidine-rich glycoprotein as suggested by sequence homology with antithrombin III. Koide T; Foster D; Odani S FEBS Lett; 1986 Jan; 194(2):242-4. PubMed ID: 3000827 [TBL] [Abstract][Full Text] [Related]
11. A heme- and metal-binding hexapeptide from the sequence of rabbit plasma histidine-rich glycoprotein. Morgan WT; Deaciuc V; Riehm JP J Mol Recognit; 1989 Nov; 2(3):122-6. PubMed ID: 2636901 [TBL] [Abstract][Full Text] [Related]
12. Further characterization of the interaction of histidine-rich glycoprotein with heparin: evidence for the binding of two molecules of histidine-rich glycoprotein by high molecular weight heparin and for the involvement of histidine residues in heparin binding. Burch MK; Blackburn MN; Morgan WT Biochemistry; 1987 Nov; 26(23):7477-82. PubMed ID: 3427089 [TBL] [Abstract][Full Text] [Related]
13. The histidine-rich glycoprotein of serum has a domain rich in histidine, proline, and glycine that binds heme and metals. Morgan WT Biochemistry; 1985 Mar; 24(6):1496-501. PubMed ID: 3986189 [TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of rat plasma antithrombin III. Takahara H; Sinohara H Biochim Biophys Acta; 1980 Mar; 612(1):185-94. PubMed ID: 7362830 [TBL] [Abstract][Full Text] [Related]
15. Structural studies on yeast 3-phosphoglycerate kinase. Isolation by affinity chromatography and characterization of the peptides produced by cyanogen bromide cleavage. Location of the single cysteinyl residue in the primary structure. Fattoum A; Roustan C; Feinberg J; Desvages G; Pradel LA Eur J Biochem; 1978 Jan; 82(1):161-7. PubMed ID: 340228 [TBL] [Abstract][Full Text] [Related]
16. Cleavage of bacterial flagellin with cyanogen bromide. Chemical and physical properties of the protein fragments. Parish CR; Ada GL Biochem J; 1969 Jul; 113(3):489-99. PubMed ID: 5807209 [TBL] [Abstract][Full Text] [Related]
17. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability. Koide T; Odani S; Takahashi K; Ono T; Sakuragawa N Proc Natl Acad Sci U S A; 1984 Jan; 81(2):289-93. PubMed ID: 6582486 [TBL] [Abstract][Full Text] [Related]
18. Interaction of heparin with histidine-rich glycoprotein and with antithrombin III. Lijnen HR; van Hoef B; Collen D Thromb Haemost; 1983 Aug; 50(2):560-2. PubMed ID: 6415849 [TBL] [Abstract][Full Text] [Related]
19. Purification and properties of guinea pig antithrombin III. Heck L; Rosenberg R; Remold H Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072 [TBL] [Abstract][Full Text] [Related]
20. Proteolysis of histidine-rich glycoprotein in plasma and in patients undergoing thrombolytic therapy. Smith A; Nuiry I; Morgan WT Thromb Res; 1985 Dec; 40(5):653-61. PubMed ID: 2935971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]